Regular Article| Volume 95, ISSUE 7, P571-576, July 2001

Download started.


Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaledβ2 -agonist formoterol upon endurance performance in healthy well-trained athletes

      This paper is only available as a PDF. To read, Please Download here.


      Inhaled β2-agonists have been subject to restrictions in relationship to sports due to fear of possible improvement in endurance performance. According to the international doping regulations only inhaled salbutamol, terbutaline and salmeterol are allowed for use in sports. Formoterol is a recently introduced rapid onset-long-acting inhaled β2-agonist.
      The main aim of the present randomized, double-blind placebo-controlled study was to investigate possible improvement in endurance performance of inhaled formoterol in 24 healthy well-trained competitive male athletes, 21–29 years old.
      Lung function (flow–volume loops) was measured before, 15 min after each inhaled study drug and before and repeatedly after exercise. On day 1, maximum oxygen uptake (VO2max), peak ventilation (VEpeak) and running time till exhaustion were measured and used to determine the exercise load on days 2 and 3. On days 2 and 3 the subjects inhaled the study drugs, rested for 1 h, then exercised, and VO2max, VEpeakand running time until exhaustion were determined.
      Inhaled formoterol did not improve any parameter of endurance performance. On the other hand a statistically significant, although not clinically significant (0·05 ml−1min kg−1), change was found in estimated difference of VO2maxbetween formoterol and placebo in favour of placebo. Lung function increased significantly after inhaled formoterol, and after exercise also for placebo, but without differences between the β2-agonist and placebo after exercise.
      In conclusion, inhaled formoterol did not improve endurance performance compared to placebo.




        • Carlsen KH
        • Boe J
        Exercise-induced asthma in children.
        Eur Respir J. 1993; 6: 614-616
        • Green CP
        • Price JF
        Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
        Arch Dis Child. 1992; 67: 1014-1017
        • Boner AL
        • Spezia E
        • Piovesan P
        • Chiocca E
        • Maiocchi G
        Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
        Am J Respir Crit Care Med. 1994; 149: 935-939
        • Heir T
        • Oseid S
        Self-reported asthma and exercise-induced asthma symptoms in high-level competetive cross-country skiers.
        Scand J Med Sci Sports. 1994; 4: 128-133
        • Spann C
        • Winter ME
        Effect of clenbuterol on athletic performance.
        Ann Pharmacother. 1995; 29: 75-77
        • Carlsen KH
        • Ingjer F
        • Thyness B
        • Kirkegaard H
        The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes.
        Scand J Med Sci Sports. 1997; 7: 160-165
        • Morton AR
        • Joyce K
        • Papalia SM
        • Carroll NG
        • Fitch KD
        Is salmeterol ergogenic?.
        Clin J Sport Med. 1996; 6: 220-225
        • Robertson W
        • Simkins J
        • O'Hickey SP
        • Freeman S
        • Cayton RM
        Does single dose salmeterol affect exercise capacity in asthmatic men?.
        Eur Respir J. 1994; 7: 1978-1984
        • Åstrand PO
        • Rodahl K
        Textbook of Work Physiology. McGraw-Hill, New York1986
        • Larsson K
        • Ohlsen P
        • Larsson L
        • Malmberg P
        • Rydstrom PO
        • Ulriksen H
        High prevalence of asthma in cross country skiers.
        BMJ. 1993; 307: 1326-1329
        • Mannix ET
        • Farber MO
        • Palange P
        • Galassetti P
        • Manfredi F
        Exercise-induced asthma in figure skaters.
        Chest. 1996; 109: 312-315
        • Provost Craig MA
        • Arbour KS
        • Sestili DC
        • Chabalko JJ
        • Ekinci E
        The incidence of exercise-induced bronchospasm in competitive figure skaters.
        J Asthma. 1996; 33: 67-71
        • Helenius IJ
        • Tikkanen HO
        • Haahtela T
        Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen.
        Br J Sports Med. 1998; 32: 125-129
        • Carlsen KH
        • Ingjer F
        • Kirkegaard H
        • Thyness B
        The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes.
        Scand J Med Sci Sports. 1997; 7: 160-165
        • Carlsen KH
        • Røksund O
        • Olsholt K
        • Njå F
        • Leegaard J
        • Bratten G
        Overnight protection by inhaled salmeterol on exercise-induced asthma in children.
        Eur Respir J. 1995; 8: 1852-1855
        • Van Noord JA
        • Smeets J
        • Raaijmakers JA
        • Bommer AM
        • Maesen FP
        Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action.
        Eur Respir J. 1996; 9: 1684-1688
        • Newnham DM
        • Grove A
        • McDevitt DG
        • Lipworth BJ
        Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
        Thorax. 1995; 50: 497-504
        • Bhagat R
        • Kalra S
        • Swystun VA
        • Cockcroft DW
        Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
        Chest. 1995; 108: 1235-1239